Here are the sales figures for the first quarter for the 10 top selling drugs Merck & Co. has:
PRODUCT NAME CONDITION/USE 1 Q 2011 SALES 1 Q 2010 SALES PERCENTAGE CHANGE IN
Singulair asthma and allergies 1.33 billion $ 1.16 billion from $ up to 14
Januvia and 1.04 billion Janumet diabetes 712 million up to 47
Rheumatoid arthritis Remicade 753 $ 674 million to 12 million
High cholesterol levels Zetia 582 $ 534 million to 9 million
Vytorin High cholestrol 480 $ 477 million dollars up to 1 million
HYZAAR and Hyzaar high-pressure 426 blood $ 782 million $ 46 million
NASONEX Allergies 373 $ 320 million to 17 million
Treatment of the HIV ISENTRESS 292 $ 232 million to 26 million
Brain cancer Temodar 248 million of $ 274 million to low 10
Vaccine against HPV Gardasil 214 million of low 8 $ 233 million
